Aker BioMarine and Acasti Pharma enter krill oil supply agreement

The partnership with NASDAQ-listed, biopharmaceutical innovator Acasti will see Aker supply krill oil as core ingredient for a new hypertriglyceridemia drug

picture of

Breaking News

C2 Pharma expands API portfolio

Micronised grade Digoxin has been a particular focus of the expanded offerings with tech transfers and more new APIs in ...

Merck makes nanoparticle-reduced sucrose with new filtration process

The product is based on a new filtration-based manufacturing process for reduced levels of nanoparticle impurities in ...

HTL ups GMP production capacity of injectable-grade sodium hyaluronate

The French facility will multiply HTL Biotechnology’s injectable-grade sodium hyaluronate production capacity by 2.5 ...

Hurdles and opportunities in the pharmaceutical outsourcing industry

The past decade has seen vast growth across the CDMO market, says Andrew Henderson, Sales and Marketing Director, ...

Bioiberica launches natural origin thyroid API

The company is also investigating new opportunities in glycosaminoglycans, complex lipids, proteins and bioactive ...

Biotin technology under pressure following FDA warning to lab staff

Biotin, aka vitamin B7, is a water-soluble vitamin often found in nutraceutical products marketed for hair, skin and ...

Medical cannabis made in Italy

Dr Fabio Di Francesco, a compounding pharmacist based in Rome, describes how cannabis is used in medicinal formulations ...

Nanoform wins CPhI Excellence in Pharma Award for Formulation

The award recognises proprietary CESS nanonisation technology

XPhyto Therapeutics inks distribution deal with cannabis grower

The supplier is an international grower and extractor with ongoing EU GMP certification for high THC flower and outdoor ...

Causes and solutions for dark spots in tablet manufacturing

Natoli Engineering examines the causes and solutions for dark spots that can halt production

Beximco Pharma: The Bangladeshi company connecting with the US

COO Rabbur Reza talks about the strategy behind approaching pharmaceutical manufacturing from an emerging market

Outsourcing in-house processes and releasing capacity

Mark Riemer, Commercial Manager at SternMaid describes the benefits of outsourcing and the services that a good ...

Cycle Pharmaceuticals chooses Catalent for rare disease therapies

This agreement covers four products in rare metabolic and neurological disorders and each product will utilise ...

New microbiome specialist raises $82m and partners with Thermo Fisher

Arranta Bio will have access to Thermo Fisher’s full suite of products and services and will provide materials to ...